Singapore markets closed

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7500+0.0024 (+0.32%)
At close: 04:00PM EDT
0.7313 -0.02 (-2.49%)
After hours: 06:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 28.44M
Enterprise value -43.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.50
Price/book (mrq)0.27
Enterprise value/revenue -18.31
Enterprise value/EBITDA 0.93

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-45.26%
S&P500 52-week change 322.55%
52-week high 31.5600
52-week low 30.7200
50-day moving average 30.9092
200-day moving average 31.0405

Share statistics

Avg vol (3-month) 3230.5k
Avg vol (10-day) 3135.18k
Shares outstanding 538.13M
Implied shares outstanding 638.13M
Float 821.43M
% held by insiders 13.47%
% held by institutions 164.19%
Shares short (14 Jun 2024) 41.85M
Short ratio (14 Jun 2024) 44.28
Short % of float (14 Jun 2024) 46.07%
Short % of shares outstanding (14 Jun 2024) 44.86%
Shares short (prior month 15 May 2024) 42.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-324.08%

Management effectiveness

Return on assets (ttm)-26.81%
Return on equity (ttm)-48.14%

Income statement

Revenue (ttm)11.32M
Revenue per share (ttm)0.30
Quarterly revenue growth (yoy)188.80%
Gross profit (ttm)N/A
EBITDA -73.03M
Net income avi to common (ttm)-63.03M
Diluted EPS (ttm)-1.6600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)91.35M
Total cash per share (mrq)2.4
Total debt (mrq)19.57M
Total debt/equity (mrq)18.79%
Current ratio (mrq)5.68
Book value per share (mrq)2.73

Cash flow statement

Operating cash flow (ttm)-62.88M
Levered free cash flow (ttm)-34.51M